MedAssets reiterates guidance for FY12 adjusted EPS $1.10 at midpoint Consensus $1.12. Reiterates view of FY12 revenue $635.0M at midpoint, consensus $636.2M. Says consolidated net revenue guidance increased by about 1.5% following its Q3 report based on nine]month 2012 performance and visibility through remainder of year. Says YTD 2012 results ahead of its expectations. Guidance and comments from presentation slides for J.P. Morgan Healthcare Conference.
News For MDAS From The Last 14 Days
Check below for free stories on MDAS the last two weeks.